Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
PAAB logo on DTCA
-
Hi. We've used both PAAB and ASC to provide an opinion service for DTC pieces. ASC does not require their logo on these pieces (although they recommend it). Does PAAB require their logo and if so, why? Thank you.
-
Hi there,
Thank you for your question.
The inclusion of the logo is preferred but not mandatory. Our logo is intended to be an indicator to the audience that the APS has undergone an independent review to meet high standards that help support the health and safety of Canadians.
-
@jennifer-carroll
Thank you for your quick reply! In the 'no objection' letter, there seems to be an expiry date. From what I understand of these types of opinion reviews, there is no expiry. Can you please clarify? Thank you. -
The “no objection” number has an expiry date because product monographs may change, new products come to market and some Health Canada regulations are in a state of transition. What may be in line with regulations today may not be necessarily true in the future. The renewal/re-submission process helps ensure that previously reviewed ads continue to meet regulations.
